ANGELA LE: Open Payments
NPI 1205605730 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,704 in 191 payments from 50 companies in 2025. Trend: 2023 $233 · 2024 $2,198 · 2025 $4,704
Food & beverage: $4,467Education: $278
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $492 |
| Regeneron Healthcare Solutions, Inc. | 10 | $426 |
| Novartis Pharmaceuticals Corporation | 21 | $406 |
| Janssen Biotech, Inc. | 15 | $398 |
| AstraZeneca Pharmaceuticals LP | 7 | $234 |
| ABBVIE INC. | 11 | $191 |
| TerSera Therapeutics LLC | 7 | $161 |
| PFIZER INC. | 8 | $145 |
| Stemline Therapeutics Inc. | 2 | $126 |
| Aveo Pharmaceuticals, Inc. | 3 | $117 |
Products named: LIBTAYO, Enhertu, RYBREVANT, KISQALI, Orserdu, IBRANCE, FOTIVDA, SCEMBLIX.
Industry payments across KS — which companies pay providers there.
